BioNTech SE (BNTX.VI) Stock Price, News & Chart

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close79.50

Open80.60

Day range80.6081.15

52-week range68.65104.00

Off day high0.00%

Off 52-week high−21.97%

Volume0.00

Avg. volume (3M)200

Market cap20.12B

EPS (TTM)-5.88

Forward P/E—

P/E ratio (TTM)—

Dividend yield—

Beta (5Y)1.33

Shares outstanding247.93M

Short interest—

Earnings dateNov 3, 2026

Analyst target—

Profit margin−63.64%

Against its peers

Compare in full ›

	BNTX.VI	688382.SS	ROIV	6IB.F	GMAB	1875.HK
Market cap	20.12B	8.38B	27.61B	17.27B	33.89B	2.56B
P/E (TTM)	—	—	—	123.8	43.4	—
Forward P/E	—	-43.8	-27.5	—	34.9	42.9
Price/book	1.1	6.6	6.5	6.2	5.5	3.8
Dividend yield	—	—	—	—	—	—
1-year change	−10.47%	−48.70%	+85.85%	−1.76%	+91.12%	+69.54%
Today	+2.08%	+4.33%	+6.08%	+3.42%	−0.72%	+5.54%

The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.

Related companies

Compare ›

The businesses closest to BioNTech's by what they do, from their descriptions, with the same industry weighted in.

Company	Mkt cap	Price	Today
InventisBio Co., Limited688382.SS · Biotechnology	8.38B	14.45	+4.33%
Roivant Sciences Ltd.ROIV · Biotechnology	27.61B	38.23	+6.08%
Innovent Biologics, Inc.6IB.F · Biotechnology	17.27B	9.91	+3.42%
Genmab A/SGMAB · Biotechnology	33.89B	55.12	−0.72%
BioDlink International Company Limited1875.HK · Biotechnology	2.56B	3.525	+5.54%
Vir Biotechnology, Inc.VIR · Biotechnology	1.99B	11.77	+4.90%
BioInvent International AB (publ)BINV.ST · Biotechnology	252.69M	3.8400	+7.11%
BioArctic AB (publ)B9A.F · Biotechnology	2.45B	27.58	−0.29%

Other companies in Biotechnology, closest in size first.

Company	Mkt cap	Price	Today
InnoCare Pharma Limited9969.HK · Beijing, China	21.56B	12.200	+1.33%
Keymed Biosciences Inc.2162.HK · Chengdu, China	20.67B	70.150	+2.48%
WuXi Biologics (Cayman) Inc.1FW1.F · Wuxi, China	22.64B	11.00	−0.90%
Daesung Microbiological Labs. Co., Ltd.036480.KQ · Uiwang-si, South Korea	19.61B	5,160.00	−4.62%
Bavarian Nordic A/SBAVA.CO · Hellerup, Denmark	18.62B	249.60	+1.13%
InSilico Medicine Cayman TopCo3696.HK · Hong Kong, Hong Kong	22.80B	39.380	0.00%
Alnylam Pharmaceuticals, Inc.ALNY · Cambridge, MA Odds	21.57B	161.08	+0.74%
Hebei Changshan Biochemical Pharmaceutical Co., Ltd.300255.SZ · Shijiazhuang, China	18.94B	20.61	+3.15%

Healthcare companies of a similar market value (19.71B).

Company	Mkt cap	Price	Today
InnoCare Pharma Limited9969.HK · Biotechnology	21.56B	12.200	+1.33%
Sartorius AktiengesellschaftSRT3.DE · Medical Instruments & Supplies	20.23B	293.00	+1.56%
Indoco Remedies LimitedINDOCO.BO · Drug Manufacturers - Specialty & Generic	19.77B	214.50	+0.14%
Hybio Pharmaceutical Co., Ltd.300199.SZ · Drug Manufacturers - Specialty & Generic	21.97B	24.87	+9.51%
Seoul Pharma Co., Ltd018680.KQ · Drug Manufacturers - Specialty & Generic	19.81B	1,699.00	0.00%
Eurofins Scientific SE0MV5.IL · Diagnostics & Research	19.76B	88.68	+0.77%
Keymed Biosciences Inc.2162.HK · Biotechnology	20.67B	70.150	+2.48%
Terumo CorporationTUO.F · Medical Devices	21.09B	14.30	+8.79%

Also based in Mainz, Germany, then elsewhere in Germany.

Company	Mkt cap	Price	Today
Quantum Cyber N.V.QUCY · Mainz, Germany	64.80M	0.7430	+2.65%
SAP SESAP · Walldorf, Germany	277.06B	240.04	+4.22%
Bayer AktiengesellschaftBAYN.F · Leverkusen, Germany	54.66B	55.64	+2.70%
BASF SEBASF.BD · Ludwigshafen am Rhein, Germany	17.22T	20,000.00	+2.36%
Bayerische Motoren Werke AktiengesellschaftBMW.BD · Munich, Germany	12.00T	20,040.00	−9.16%
Siemens AktiengesellschaftSIE.F · Munich, Germany	213.90B	279.90	+1.08%
Volkswagen AGVOW3N.MX · Wolfsburg, Germany	722.80B	1,441.86	0.00%
Allianz SEALV.F · Munich, Germany	176.37B	465.00	+1.33%

The stocks whose daily moves over the past year went most closely with BioNTech's: the correlation of their daily returns, where 1 would be moving as one.

Company	Mkt cap	Price	Today
Vir Biotechnology, Inc.VIR · Correlation 0.31	1.99B	11.77	+4.90%

From the 4SEARCH.business instruments index: what each company does (its business description), its industry, size, headquarters and the markets it serves; and from a year of daily prices, which move together. Prices may be delayed up to 20 min.

Latest news

All BNTX.VI news ›

Seeking Alpha·20h agoNegative

BioNTech Q3: Bristol Myers Revenue Masks A Narrowing Oncology Bet (Rating Downgrade)

BioNTech earns a Hold rating as cash burn, pipeline narrowing, and two-asset concentration raise risk. Click here to read an analysis of BNTX stock now. - BioNTech is rated Hold due to a narrowing pipeline, negative cash flow, and reliance…

BMY

FinSMEs·21h agoPositive

Emvena Therapeutics Receives Investment From Penn-BioNTech Innovative Therapeutics Seed Fund

FinSMEs Emvena Therapeutics Receives Investment From Penn-BioNTech Innovative Therapeutics Seed Fund Emvena Therapeutics, a Philadelphia, PA-based biotechnology company developing mRNA medicines designed to

AZN SNY

Seeking Alpha·7h ago

BioNTech SE 2026 Q3 - Results - Earnings Call Presentation

2026-11-04. The following slide deck was published by BioNTech SE in conjunction with their 2026 Q3 earnings call. The following slide deck was published by BioNTech SE in conjunction with their 2026 Q3 earnings call. Q3: 2026-11-03…

BNTX BBNX BHST

Markets Daily·10h agoNegative

BioNTech (NASDAQ:BNTX) Price Target Cut to $125.00 by Analysts at UBS Group

Posted by Mitch Edgeman on Nov 4th, 2026 BioNTech (NASDAQ:BNTX – Get Free Report) had its target price decreased by analysts at UBS Group from $135.00 to $125.00 in a research report issued on Wednesday, Benzinga reports. The firm…

BNTX BIIB BCS PFE

Seeking Alpha·1d agoPositive

BioNTech outlines 2026 revenue guidance of €1.7B-€1.9B as it anticipates gotistobart interim analysis before year-end

BioNTech Q3 2026 earnings: raised revenue guidance, oncology pipeline progress, and key trial risks. Earnings Call Insights: BioNTech (BNTX) Q3 2026 CEO Ugur Sahin said, “We have made good progress against our strategic milestones set out…

BIIB BNTX PFE BMY

The Globe and Mail·2d ago

J.P. Morgan Sticks to Their Hold Rating for BioNTech SE (BNTX)

J.P. Morgan analyst Jessica Fye maintained a Hold rating on BioNTech SE today and set a price target of $86.86. According to TipRanks, Fye is a 4-star analyst with an average return of 4.1% and a 52.20% success rate. Fye covers the…

BNTX JEF

GenomeWeb·1d ago

After mRNA Trial Setbacks, BioNTech Still Pushing Ahead in Cancer

Despite Trial Misses, BioNTech Keeps Focused on mRNA Cancer Therapies GenomeWeb Despite Trial Misses, BioNTech Keeps Focused on mRNA Cancer Therapies

MRNA PFE LLY

TradingView·1d agoNegative

BioNTech: Higher FY revenue guidance and advancing oncology trials offset pipeline and demand uncertainties

TradingView BioNTech: Higher FY revenue guidance and advancing oncology trials offset pipeline and demand uncertainties Q3 revenue declined as COVID-19 vaccine demand fell, but stronger partn

BNTX NVDA BIIB SPCX

Pluang·1d agoPositive

BioNTech reports Q3 2026 revenues of €1.29B, advances oncology pipeline, raises 2026 revenue guidance

BioNTech announced its third quarter 2026 financial results with revenues of €1.29 billion, driven by ongoing COVID-19 vaccine sales despite lower demand. The company highlighted progress in its oncology pipeline, including new Phase 3…

BNTX BIIB PFE

Stock Titan·Oct 22Positive

BioNTech to test pumitamig-Trodelvy breast cancer combo

Rising Dragon Acquisition Corp. and HZJL Cayman Limited Announce Mutual Termination of Merger Agreement Cipher, a Prosegur Company, and BIO-key Announce Technology Integration to Expand Identity Security Offering, Starting in Portugal…

BNTX BMY PFE GILD

From the 4Search news index, newest first.

In the news

89mentions in 30 days

89with it in the headline

Mixedsentiment

Most coverage from

marketscreener.com17
stocktitan.net10
markets.businessinsider.com9
themarketsdaily.com7
247wallst.com6

Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 89 articles, not a forecast.

Key statistics

Against its peers

Related companies

Latest news

In the news

Mentioned with

People in the coverage

Themes

Most coverage from